Israa Sharkia
Papers
2
Total Citations
16
H-Index
2
About
Dr. Israa Sharkia is a molecular diagnostics researcher whose work has been pivotal in scaling up testing capacity during the SARS-CoV-2 pandemic. Her primary research focus lies in developing innovative, high-throughput viral detection methodologies that bypass traditional bottlenecks. Dr. Sharkia’s major contribution is the creation of extraction-free, early-pooling protocols, most notably **ApharSeq** and a subsequent refined method for simultaneous detection and variant sequencing. These techniques revolutionized SARS-CoV-2 testing by enabling massively multiplexed sample processing, dramatically increasing throughput while conserving reagents and reducing costs. Her most cited work, "Early sample tagging and pooling enables simultaneous SARS-CoV-2 detection and variant sequencing" (11 citations), demonstrates a key advancement by integrating diagnostic detection with genomic surveillance in a single workflow. This approach allowed for the rapid identification of emerging variants directly from pooled samples, a critical capability for public health response. Dr. Sharkia’s contributions have been instrumental in moving beyond traditional RNA extraction and RT-qPCR limitations, offering scalable solutions that have enhanced global pandemic preparedness and molecular epidemiology.
Research Focus
Key Achievements
Top Papers
- 1
- 2